Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects.
about
Modulation of the gut microbiota by nutrients with prebiotic and probiotic propertiesLactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects.Metagenomic Sequencing Indicates That the Oropharyngeal Phageome of Individuals With Schizophrenia Differs From That of Controls.Gut microorganisms as promising targets for the management of type 2 diabetes.The Role of Probiotics on the Microbiota: Effect on Obesity.Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials.Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity.Effect of Probiotics on Blood Lipid Concentrations: A Meta-Analysis of Randomized Controlled TrialsDeciphering bacterial community changes in zucker diabetic fatty rats based on 16S rRNA gene sequences analysis.In vitro investigation of molecules involved in Lactobacillus gasseri SBT2055 adhesion to host intestinal tract components.Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure.Probiotics, prebiotics, synbiotics and insulin sensitivity.Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue.Gut microbiota and obesity.
P2860
Q26823918-9B668874-ABB2-48CD-AB3F-39896673B321Q35339196-8FA460DF-BD8B-45BB-8B53-2C1A0E2E3D56Q35558549-F7CCF7EA-9443-48C9-9D29-BAA06F1B0E41Q35725065-DFE8FDB3-6800-4D23-B707-72ADEC6B85ACQ35921722-639EF83A-EBA0-41E6-BAE6-D1C5995D2FB4Q36122235-9A478BFB-2E8E-49AD-B497-C7D6974AA4F6Q36694416-AF9C1A8A-C599-4907-A78E-6340BC064B79Q37176141-5C5FA2A4-CF8E-417B-B0E9-035243A0EB61Q37580144-96CDC37B-1987-4D77-9D27-A0E2DAD51E45Q39136726-44B7321A-D274-4ECF-939B-96A5C4EE586AQ39137793-67B8377C-FEF3-494D-8658-306C3B6F07C2Q47645890-1F607443-9689-4DFF-95CE-EE69E7320979Q51193316-E2553BB8-AC3D-4EB6-B332-54B5996E14BFQ53489619-18E54070-AB67-4D89-B37E-607B8746BC6D
P2860
Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lactobacillus gasseri SBT2055 ...... rtriacylglycerolemic subjects.
@en
Lactobacillus gasseri SBT2055 ...... rtriacylglycerolemic subjects.
@nl
type
label
Lactobacillus gasseri SBT2055 ...... rtriacylglycerolemic subjects.
@en
Lactobacillus gasseri SBT2055 ...... rtriacylglycerolemic subjects.
@nl
prefLabel
Lactobacillus gasseri SBT2055 ...... rtriacylglycerolemic subjects.
@en
Lactobacillus gasseri SBT2055 ...... rtriacylglycerolemic subjects.
@nl
P2093
P2860
P356
P1476
Lactobacillus gasseri SBT2055 ...... rtriacylglycerolemic subjects.
@en
P2093
Akihiro Ogawa
Bungo Shirouchi
Masao Sato
Yukio Kadooka
P2860
P2888
P356
10.1186/1476-511X-13-36
P577
2014-02-19T00:00:00Z
P6179
1045704509